Study of a heart imaging tool during heart procedures
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at a new ultrasound tool that helps doctors see inside the heart during certain heart procedures. It may help guide the procedure more safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years old or older
- Willing to sign a consent form
- Having a heart procedure that uses the VeriSight Pro imaging tool
- Not pregnant
- No conditions that make using the imaging tool unsafe, such as severe infections, blood clotting problems, a clot in the heart, severe angina or heart failure, deep vein thrombosis, or significant blood vessel disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special imaging tool inside the heart to guide a new type of energy (pulsed field) to treat a specific area in the heart that can cause atrial fibrillation (an irregular heartbeat). It may help people with paroxysmal or persistent atrial fibrillation who need a procedure called CTI ablation.
This study tests a software tool (EPX-HTG) that helps doctors see your heart more clearly during certain structural heart procedures. It might help improve the accuracy of the procedure and is for people having LAAO or M-TEER.
This study looks at how often silent brain lesions happen after a new type of heart procedure for atrial fibrillation (an irregular heartbeat). The procedure uses a device called the Varipulse catheter to help fix the heart's rhythm.
This study tests a new imaging system (VERAFEYE) that helps doctors guide catheter ablation, a procedure to fix irregular heartbeats like atrial fibrillation. It aims to see if the system makes the procedure safer or more effective.
This study tests a new imaging system that helps doctors see inside the heart during a procedure to treat atrial fibrillation (an irregular heartbeat). It may allow for more precise treatment and improve outcomes for people with this condition.
This study tests a new imaging catheter (VERAFEYE) to help doctors guide ablation procedures for atrial flutter or atrial fibrillation. It may lead to safer, more precise treatment of these heart rhythm problems.
Hear when a new ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.